481 related articles for article (PubMed ID: 37984863)
1. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
[TBL] [Abstract][Full Text] [Related]
2. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
3. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.
Wendlocha D; Kubina R; Krzykawski K; Mielczarek-Palacz A
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674891
[TBL] [Abstract][Full Text] [Related]
4. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
6. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
7. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
9. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
Wang X; Hua P; He C; Chen M
Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
[TBL] [Abstract][Full Text] [Related]
11. Targeting regulated cell death in tumor nanomedicines.
Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
[TBL] [Abstract][Full Text] [Related]
12. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
Wang Y; Wang Y; Pan J; Gan L; Xue J
Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
15. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
[TBL] [Abstract][Full Text] [Related]
16. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
Zhou P; Zhang S; Wang M; Zhou J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine-induced programmed cell death enhances tumor immunotherapy.
Lu J; Tai Z; Wu J; Li L; Zhang T; Liu J; Zhu Q; Chen Z
J Adv Res; 2023 Sep; ():. PubMed ID: 37743016
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
Zhou S; Liu J; Wan A; Zhang Y; Qi X
J Hematol Oncol; 2024 Apr; 17(1):22. PubMed ID: 38654314
[TBL] [Abstract][Full Text] [Related]
19. The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury.
Ning J; Chen L; Zeng Y; Xiao G; Tian W; Wu Q; Tang J; He S; Tanzhu G; Zhou R
Int J Biol Sci; 2024; 20(5):1871-1883. PubMed ID: 38481804
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
